Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nigel H. Russell
4173  Ergebnisse:
Personensuche X
?
1

Optimal Prognostic Threshold for Acute Myeloid Leukemia (AM..:

Rodríguez-Arbolí, Eduardo ; Othus, Megan ; Freeman, Sylvie...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S9 , 2024
Link: https://doi.org/10.1016/..
 
?
2

A randomized comparison of CPX-351 and FLAG-Ida in adverse ..:

Othman, Jad ; Wilhelm-Benartzi, Charlotte ; Dillon, Richard...
Blood Advances.  7 (2023)  16 - p. 4539-4549 , 2023
Link: https://doi.org/10.1182/..
 
?
3

Fractionated vs single-dose gemtuzumab ozogamicin with dete..:

Freeman, Sylvie D. ; Thomas, Abin ; Thomas, Ian...
Blood.  142 (2023)  20 - p. 1697-1707 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Frontline Management of Acute Myeloid Leukaemia Eligible fo..:

, In: Pathogenesis and Treatment of Leukemia,
Tauro, Sudhir ; Russell, Nigel H. - p. 91-110 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Patient, Family Member and Physician Perspectives and Exper..:

LeBlanc, Thomas W. ; Russell, Nigel H. ; Hernandez-Aldama, Loriana...
Oncology and Therapy.  10 (2022)  2 - p. 421-440 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Author Correction: Genome-wide association study identifies..:

Lin, Wei-Yu ; Fordham, Sarah E. ; Hungate, Eric...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
7

A randomised comparison of FLAG‐Ida versus daunorubicin com..:

Russell, Nigel H. ; Hills, Robert K. ; Kjeldsen, Lars...
British Journal of Haematology.  198 (2022)  3 - p. 528-534 , 2022
Link: https://doi.org/10.1111/..
 
?
8

A randomised evaluation of low‐dose Ara‐C plus pegylated re..:

Mussai, Francis ; De Santo, Carmela ; Cheng, Paul...
British Journal of Haematology.  200 (2022)  5 - p. 573-578 , 2022
Link: https://doi.org/10.1111/..
 
?
9

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR..:

Loo, Sun ; Dillon, Richard ; Ivey, Adam...
Blood.  140 (2022)  22 - p. 2407-2411 , 2022
Link: https://doi.org/10.1182/..
 
?
10

Unified classification and risk-stratification in Acute Mye..:

Tazi, Yanis ; Arango-Ossa, Juan E. ; Zhou, Yangyu...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
11

Clinical impact of NPM1-mutant molecular persistence after ..:

Tiong, Ing S. ; Dillon, Richard ; Ivey, Adam...
Blood Advances.  5 (2021)  23 - p. 5107-5111 , 2021
Link: https://doi.org/10.1182/..
 
?
12

Future Developments: Measurable Residual Disease:

, In: Acute Myeloid Leukemia; Hematologic Malignancies,
Venditti, Adriano ; Valk, Peter J. M. ; Russell, Nigel H.. - p. 317-337 , 2021
Link: https://doi.org/10.1007/..
 
?
13

Outcomes of older patients aged 60 to 70 years undergoing r..:

Russell, Nigel H. ; Hills, Robert K. ; Thomas, Abin...
Haematologica.  107 (2021)  7 - p. 1518-1527 , 2021
Link: https://doi.org/10.3324/..
 
?
14

Characteristics and outcome of patients with acute myeloid ..:

Kayser, Sabine ; Hills, Robert K. ; Langova, Ralitsa...
British Journal of Haematology.  192 (2021)  5 - p. 832-842 , 2021
Link: https://doi.org/10.1111/..
 
?
15

Gemtuzumab ozogamicin in (KMT2A)‐rearranged adult acute mye..:

Dillon, Richard ; Hills, Robert K. ; Burnett, Alan K..
British Journal of Haematology.  196 (2021)  5 - p. , 2021
Link: https://doi.org/10.1111/..
 
1-15